| Date Filed | Type | Description |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/16/2023 |
4
| Meyers James R (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.57, valued at
$39.3k
|
|
| 06/16/2023 |
4
| Mohindru Mani (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.57, valued at
$39.3k
|
|
| 06/16/2023 |
4
| Young Matthew P. (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.57, valued at
$39.3k
|
|
| 06/16/2023 |
4
| Ashworth Alan (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.57, valued at
$39.3k
|
|
| 06/16/2023 |
4
| Gilbert Halley E (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.57, valued at
$39.3k
|
|
| 06/16/2023 |
4
| Jones Elaine V (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.57, valued at
$39.3k
|
|
| 05/23/2023 |
4
| McCarthy Sean A. (CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Exercised 16,535 options to buy
@ $1.5749, valued at
$26k
|
|
| 03/31/2023 |
4
| Jones Elaine V (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $1.55, valued at
$7.8k
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| ROWLAND LLOYD A (General Counsel) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Sold 2,037 shares
@ $1.979, valued at
$4k
|
|
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2022 |
4
| McCarthy Sean A. (CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 450,000 options to buy
@ $1.59, valued at
$715.5k
Granted 75,000 options to buy
@ $0 |
|
| 08/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2022 |
4
| Peterson Amy C. (EVP, Chief Development Officer) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Sold 7,463 shares
@ $1.422, valued at
$10.6k
|
|
| 07/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2022 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Sold 14,911 shares
@ $1.4222, valued at
$21.2k
|
|
| 07/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2022 |
4
| HANNAH ALISON L. (Chief Medical Officer) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Sold 5,602 shares
@ $1.4219, valued at
$8k
|
|
| 07/21/2022 |
4
| Campoy Carlos (CFO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Sold 3,949 shares
@ $1.4224, valued at
$5.6k
|
|
| 06/17/2022 |
4
| Young Matthew P. (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.72, valued at
$43k
|
|
| 06/17/2022 |
4
| Mohindru Mani (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.72, valued at
$43k
|
|
|